[Infections as oncologic emergencies].
Infektionen als Notfall der Onkologie: Übersicht über die aktuellen Leitlinien.
CNS infections
Hematologic neoplasms
Immunosuppression
Mucositis
Neutropenic fever
Sepsis
Journal
Wiener klinisches Magazin : Beilage zur Wiener klinischen Wochenschrift
ISSN: 1869-1757
Titre abrégé: Wien Klin Mag
Pays: Austria
ID NLM: 101571165
Informations de publication
Date de publication:
2020
2020
Historique:
pubmed:
24
4
2020
medline:
24
4
2020
entrez:
24
4
2020
Statut:
ppublish
Résumé
Patients with oncologic diseases, particularly those with hematologic malignancies, are at an increased risk of common infections and unique treatment-related complications with high mortality and morbidity. The annual incidence and prevalence of cancer in Germany is rising. Although modern treatments have generally led to improved survival, increasing age, comorbidities, and frailty of the patients require multidisciplinary strategies for handling complex therapeutic concepts and treatment of the associated complications. A selective literature search and guidelines from the European Society for Medical Oncology (ESMO), the German Society of Hematology and Medical Oncology ( Recognition of severe infections in cancer patients and their discrimination from treatment-associated complications is a challenge. Neutropenic fever is the most frequent infectious emergency in oncology. Early empiric treatment with broad-spectrum antibiotics and escalated diagnostic strategies are needed to successfully treat this vulnerable patient group. In this article, a range of potentially life-threatening infections in immunocompromised patients are discussed.
Sections du résumé
Background
UNASSIGNED
Patients with oncologic diseases, particularly those with hematologic malignancies, are at an increased risk of common infections and unique treatment-related complications with high mortality and morbidity. The annual incidence and prevalence of cancer in Germany is rising. Although modern treatments have generally led to improved survival, increasing age, comorbidities, and frailty of the patients require multidisciplinary strategies for handling complex therapeutic concepts and treatment of the associated complications.
Methods
UNASSIGNED
A selective literature search and guidelines from the European Society for Medical Oncology (ESMO), the German Society of Hematology and Medical Oncology (
Conclusion
UNASSIGNED
Recognition of severe infections in cancer patients and their discrimination from treatment-associated complications is a challenge. Neutropenic fever is the most frequent infectious emergency in oncology. Early empiric treatment with broad-spectrum antibiotics and escalated diagnostic strategies are needed to successfully treat this vulnerable patient group. In this article, a range of potentially life-threatening infections in immunocompromised patients are discussed.
Identifiants
pubmed: 32322312
doi: 10.1007/s00740-020-00339-z
pii: 339
pmc: PMC7175641
doi:
Types de publication
English Abstract
Journal Article
Review
Langues
ger
Pagination
131-139Informations de copyright
© Springer-Verlag GmbH Austria, ein Teil von Springer Nature 2020.
Références
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Ann Hematol. 2014 Jul;93(7):1083-95
pubmed: 24777705
J Clin Oncol. 2018 May 10;36(14):1443-1453
pubmed: 29461916
Heart Fail Rev. 2019 Nov;24(6):997-1004
pubmed: 31273537
N Engl J Med. 2004 Sep 30;351(14):1391-402
pubmed: 15459300
CA Cancer J Clin. 2008 Nov-Dec;58(6):323-46
pubmed: 18971486
Emerg Med Clin North Am. 2018 Nov;36(4):795-810
pubmed: 30297005
Haematologica. 2006 Aug;91(8):1068-75
pubmed: 16885047
Clin Microbiol Rev. 2012 Jul;25(3):450-70
pubmed: 22763634
Ann Oncol. 2015 Sep;26 Suppl 5:v152-68
pubmed: 26314776
Ann Hematol. 2017 Nov;96(11):1775-1792
pubmed: 28856437
JAMA. 2014 Dec 17;312(23):2521-30
pubmed: 25514302
Am J Gastroenterol. 2001 May;96(5):1651-2
pubmed: 11374725
Ann Oncol. 2006 Jul;17(7):1051-9
pubmed: 16410361
Ann Oncol. 2016 Sep;27(suppl 5):v111-v118
pubmed: 27664247
Ann Hematol. 2014 Jan;93(1):13-32
pubmed: 24026426
Ann Oncol. 2016 Dec;27(12):2172-2184
pubmed: 27803003
Cancer. 2006 May 15;106(10):2258-66
pubmed: 16575919
Int J Cardiol Heart Vasc. 2019 Sep 07;25:100420
pubmed: 31517036
Gastroenterology. 2003 Dec;125(6):1742-9
pubmed: 14724827
Ann Oncol. 2015 Sep;26 Suppl 5:v139-51
pubmed: 26142468
Clin Infect Dis. 2005 Nov 15;41(10):1448-52
pubmed: 16231256
Ann Hematol. 2019 May;98(5):1051-1069
pubmed: 30796468
Eur Heart J. 2013 Sep;34(33):2636-48, 2648a-2648d
pubmed: 23824828
Ann Oncol. 2017 Jul 1;28(suppl_4):iv119-iv142
pubmed: 28881921
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv126-iv142
pubmed: 29931177